FI67548B - Foerfarande foer framstaellning av terapeutiskt anvaendbara okahydro-1h-pyrrolo(2,3-g)isokinoliner - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara okahydro-1h-pyrrolo(2,3-g)isokinoliner Download PDFInfo
- Publication number
- FI67548B FI67548B FI793183A FI793183A FI67548B FI 67548 B FI67548 B FI 67548B FI 793183 A FI793183 A FI 793183A FI 793183 A FI793183 A FI 793183A FI 67548 B FI67548 B FI 67548B
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- formula
- compound
- trans
- octahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Claims (6)
1 R3 ' ru " —,r I . Ji l| IIc" H där R2', Rg* och R^"’ betecknar samma som ovan, och om sä önskas 1. isomeriserar man den erhällna blandningen av cis- och trans-isomerer sä, att man huvudsakligen erhällen trans-isomeren 2. separerar trans-isomeren frän den erhällna blandningen 3. uppdelar en erhällen racemisk blandning i optiska antipoder, och/eller 4. omvandlar en erhällen förening eller ett farmaceutiskt icke-godtagbart syraadditionssalt till ett farmaceutiskt godtag-bart syraadditionssalt.
1. A / » *2 H väri R2 är väte, C^^-alkyl, C2_7-alkenyl, C^^-alkanoyl eller fenyl-C^_7~alkyl, är väte, C^_7~alkyl, C3_g-cykloalkyl eller fenyl, är C^_7~alkyl, C^_7-hydroxialkyl, aryl-C^_7-hydroxi-alkyl, C^_7~alkoxi-C^_7alkyl, aryloxi-C^^-hydroxialkyl, aryl-karbonyloxi-C^_7~alkyl, arylkarbonyl-C^_7-alkyl, C^_7-alkoxi-karbonyl-C1_7-alkyl, aryl-C^_7-alkyl, C2_7~alkenyl, C3_g-cyklo-alkyl-C^_7~alkyl, C2_7~alkynyl, tienyl-C^_7-alkyl, furyl-C^_7~ alkyl, arylkarboxamido-C^_7-alkyl, C^_7-alkanolyl-C^_7-alkyl, C2_7~alkenyloxi-C^_7-alkyl, aryl-C2-7-alkenyl, aryloxi-C^_7~ alkyl. N-C^_7-alkyl-pyrrolidinyl-C^_7-alkyl, N-ben srmimidazol-2-oa-l-yl-C^_7-alkyl di-C^_7-alkvl-M-C^ _7~· il kyl eller morfolino-C^_7alkyl och X är 0 eller S, varvid aryl betecknar fenyl eller en med halogen, C^_7~alkyl eller C^_7~alkoxi monosubstituerad fenyl, kännetecknad därav, att a) isokinolin-kväveatomen i en förening med formeln X il R Il XV N /\r2 H där , R2, Rg och X betecknar samman som ovan, substitueras under användning av en halogenid, epoxid eller aziridin, eller b) en förening med formeln 67548 62 v\MH ,Α_^r3 i" x n x/n/^P-'Xr * k 2 där R2 och R3 betecknar samma som ovan och R^" är C^_?-alkyl, C1_7~alkoxi-C1_7-alkyl eller C3_g-cykloalkyl-C1_7-alkyl, behand-las med formaldehyd, varvid man erhäller en förening med formeln V _______ i I J1 Ia \ N / ^R0 I z H där R2, R3 och R^" betecknar samma som ovan, eller c) en förening med formeln 0 V ^ XII där R^" betecknar samma som ovan behandlas med en förening med formeln 0. ^,R„ 3 VII HON ^ R2 i närvaro av ett reduktionsmedel eller med en förening med formeln °^^R3 VIII H2N-^^ r2 eller en prekursor därav, i vilka formler R2 och R3 betecknar samma som ovan, varvid man erhäller en förening med formeln la, eller d) en förening med formeln 0 67548 63 r4,,1_ --fh' lIAhAr,' H är väte, C^-alkyl, C2._7-alkenyl eller fenyl-C1_7-alkyl, är-väte, C^^-alkyl, C3_g-cykloalkyl eller fenyl och R^"* är C1_7~alkyl, C^^-alkoxi-C.^-alkyl, aryl-C.^-alkyl, C2_7~alkenyl, C3_g-cykloalkyl-C1_7-alkyl, C2_?-alkynyl, tienyl-C1 7~alkyl, furyl-C1_7-alkyl, C2_7~alkenyloxi-C1_7-alkyl, aryl-C2_7~alkenyl eller aryloxi-C^_7~alkyl, behandlas med fos-forpentasulfid, varvid man erhälles en förening med formeln
1. Förfarande för framstäiIning av terapeutiskt användbara oktahydro-lH-pyrroloZ.2,3-g7isokinoliner med formeln A, opt iskä och geometriska isomerer därav samt farmaceutiskt godtagbara syra-additionssalter därav, X. / R3 Rh— N j, Γ)
2. Förfarande enligt patentkravet 1 för framställning av 3-ety1-2,6-dimetyl-U,4a,5,6,7,8,8a,9-oktahydro-4a,8a-trans-lH-pyrrolo/2,3-g7isokinolin-4-on, kännetecknat därav , att man säsom utgängsämne använder en pä motsvarande sätt subs-tituerad förening med formeln XV, IX eller XII.
3. Förfarande enligt patentkravet 1 för framställning av 2-metyl-3-etyl-6-(2-fenyletyl)-4,4a,5,6,7,8,8a,9-oktahydro-4a,8a-trans-lH-pyrrolo/’2 , 3-g/isokinolin-4-on , kännetecknat därav, att man säsom utgängsämne använder en pä motsvarande sätt substituerad förening med formeln XV.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI801159A FI68833C (fi) | 1979-10-12 | 1980-04-11 | Foerfarande foer framstaellning av terapeutiskt anvaendbara cyloalka(4,5)pyrrolo(2,3-g)isokinoliner |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95094778A | 1978-10-13 | 1978-10-13 | |
US95094778 | 1978-10-13 | ||
US7381379 | 1979-09-10 | ||
US06/073,813 US4260762A (en) | 1979-09-10 | 1979-09-10 | Octahydro-1H-pyrrolo[2,3-g]isoquinolines |
Publications (3)
Publication Number | Publication Date |
---|---|
FI793183A FI793183A (fi) | 1980-04-14 |
FI67548B true FI67548B (fi) | 1984-12-31 |
FI67548C FI67548C (fi) | 1985-04-10 |
Family
ID=26754910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI793183A FI67548C (fi) | 1978-10-13 | 1979-10-12 | Foerfarande foer framstaellning av terapeutiskt anvaendbara okahydro-1h-pyrrolo(2,3-g)isokinoliner |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0010661B1 (sv) |
AR (2) | AR228244A1 (sv) |
AU (1) | AU528685B2 (sv) |
CA (1) | CA1132553A (sv) |
CS (1) | CS242858B2 (sv) |
DE (1) | DE2967215D1 (sv) |
DK (1) | DK430579A (sv) |
ES (2) | ES8104805A1 (sv) |
FI (1) | FI67548C (sv) |
HU (1) | HU181883B (sv) |
IE (1) | IE48965B1 (sv) |
IL (1) | IL58438A (sv) |
MC (1) | MC1285A1 (sv) |
NO (1) | NO152873C (sv) |
NZ (1) | NZ191830A (sv) |
PH (1) | PH14835A (sv) |
PT (1) | PT70310A (sv) |
SU (3) | SU1014474A3 (sv) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MC1377A1 (fr) * | 1980-02-28 | 1982-01-19 | Hoffmann La Roche | Derives d'isoquinoleine |
DE3363146D1 (en) * | 1982-03-29 | 1986-05-28 | Hoffmann La Roche | Process for the manufacture of isoquinoline diones |
US4732902A (en) * | 1986-05-23 | 1988-03-22 | Hoffmann-La Roche Inc. | Pyrroloisoquinolinyl-dimethyloxoalkyl alkonoates and their use as antipsychotic agents |
GB8828669D0 (en) * | 1988-12-08 | 1989-01-11 | Lilly Industries Ltd | Organic compounds |
JP2002530366A (ja) * | 1998-11-20 | 2002-09-17 | ビーエーエスエフ アクチェンゲゼルシャフト | ビス(オキシム)モノエーテルを製造するための方法および中間体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51118799A (en) * | 1975-04-10 | 1976-10-18 | Sankyo Co Ltd | Method for preparing pyridindole derivatives |
-
1979
- 1979-09-27 CA CA336,495A patent/CA1132553A/en not_active Expired
- 1979-10-08 SU SU812819251K patent/SU1014474A3/ru active
- 1979-10-08 SU SU792819251A patent/SU1109052A3/ru active
- 1979-10-10 MC MC791409A patent/MC1285A1/xx unknown
- 1979-10-11 IL IL58438A patent/IL58438A/xx unknown
- 1979-10-11 DK DK430579A patent/DK430579A/da not_active Application Discontinuation
- 1979-10-11 DE DE7979103908T patent/DE2967215D1/de not_active Expired
- 1979-10-11 EP EP79103908A patent/EP0010661B1/de not_active Expired
- 1979-10-11 AU AU51697/79A patent/AU528685B2/en not_active Ceased
- 1979-10-11 NZ NZ191830A patent/NZ191830A/en unknown
- 1979-10-12 AR AR278488A patent/AR228244A1/es active
- 1979-10-12 NO NO793301A patent/NO152873C/no unknown
- 1979-10-12 PH PH23160A patent/PH14835A/en unknown
- 1979-10-12 HU HU79HO2188A patent/HU181883B/hu not_active IP Right Cessation
- 1979-10-12 IE IE1944/79A patent/IE48965B1/en unknown
- 1979-10-12 CS CS796945A patent/CS242858B2/cs unknown
- 1979-10-12 FI FI793183A patent/FI67548C/fi not_active IP Right Cessation
- 1979-10-12 PT PT70310A patent/PT70310A/pt unknown
-
1980
- 1980-07-02 ES ES493014A patent/ES8104805A1/es not_active Expired
- 1980-07-02 ES ES493015A patent/ES8104806A1/es not_active Expired
-
1981
- 1981-03-02 SU SU813250198A patent/SU1048985A3/ru active
- 1981-07-02 AR AR285961A patent/AR229096A1/es active
Also Published As
Publication number | Publication date |
---|---|
AU528685B2 (en) | 1983-05-12 |
FI67548C (fi) | 1985-04-10 |
SU1048985A3 (ru) | 1983-10-15 |
AU5169779A (en) | 1980-04-17 |
CS694579A2 (en) | 1985-08-15 |
NO793301L (no) | 1980-04-15 |
AR229096A1 (es) | 1983-06-15 |
CA1132553A (en) | 1982-09-28 |
PT70310A (en) | 1979-11-01 |
IL58438A (en) | 1982-12-31 |
IE48965B1 (en) | 1985-06-26 |
IE791944L (en) | 1980-04-13 |
HU181883B (en) | 1983-11-28 |
MC1285A1 (fr) | 1980-07-22 |
AR228244A1 (es) | 1983-02-15 |
SU1109052A3 (ru) | 1984-08-15 |
NO152873C (no) | 1985-12-04 |
EP0010661A3 (en) | 1980-10-01 |
NO152873B (no) | 1985-08-26 |
DE2967215D1 (en) | 1984-10-18 |
EP0010661A2 (de) | 1980-05-14 |
CS242858B2 (en) | 1986-05-15 |
SU1014474A3 (ru) | 1983-04-23 |
DK430579A (da) | 1980-04-14 |
PH14835A (en) | 1981-12-16 |
IL58438A0 (en) | 1980-01-31 |
ES493015A0 (es) | 1981-05-16 |
ES493014A0 (es) | 1981-05-16 |
FI793183A (fi) | 1980-04-14 |
ES8104805A1 (es) | 1981-05-16 |
NZ191830A (en) | 1984-09-28 |
ES8104806A1 (es) | 1981-05-16 |
EP0010661B1 (de) | 1984-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11891392B2 (en) | Pharmacophore for trail induction | |
EP3535256B1 (en) | Novel tetrahydroisoquinolines and terahydronaphthyridines for the treatment and prophylaxis of hepatitis b virus infection | |
US8420811B2 (en) | Tetrahydroisoquinolines and intermediates therefor | |
CN107148409B (zh) | 经取代的二环化合物 | |
US6835730B2 (en) | 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof | |
FI67548B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara okahydro-1h-pyrrolo(2,3-g)isokinoliner | |
WO2003033497A1 (en) | Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity | |
US6762191B2 (en) | Therapeutic compounds | |
US9498476B2 (en) | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine | |
WO2019246454A1 (en) | Method of treating a condition associated with neurodegeneration using inhibitors of oat3 | |
KR20200091422A (ko) | 피리디논 유도체 및 선택적 alk-2 억제제로서의 그의 용도 | |
EP3763718A1 (en) | Substituted 3,4,12,12a-tetrahydro-1h-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, pharmaceutical composition, and methods for preparing and using same | |
CZ127293A3 (en) | Biphenylquinuclidines, process of their preparation and pharmaceutical preparations in which they are comprised | |
FI68833B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara cykoalka(4,5)pyrrolo(2,3-g)isokinoliner | |
JP6041303B2 (ja) | 新規抗癌剤 | |
CA1160228A (en) | Cycloalka¬4,5|pyrrolo¬2,3-g|isoquinolines | |
US4388467A (en) | Cycloalka[4,5]pyrrolo[2,3-g]isoquinolines | |
KR850000031B1 (ko) | 사이클로알카[4,5]피롤로[2,3-g]-이소퀴놀린의 제조방법 | |
CS242900B2 (cs) | Způsob výroby oktahydro-1H-pyrroio[2,3-g]isochinolinů | |
HU189572B (en) | Process for producing 6-substituted hexahydro-indazol-isoquinolines | |
PL126673B1 (en) | Method for producing new octahydro-1h-pyrrole-/2,3-g/isoquinolines | |
NZ224356A (en) | 3,4-dihydro benzo- and thieno- pyridine derivatives and pharmaceutical compositions containing such | |
JPH01311082A (ja) | シクロアルカン[b〕インドロン及びその調剤上許容できる酸付加塩並びにその製造方法、薬剤組成物 | |
NZ702413A (en) | Compound as wnt signaling inhibitor, composition, and use thereof | |
HU199462B (en) | Process for producing pyrimido/4,5-a/quinoline derivatives and pharmaceutical compositions comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: F HOFFMANN-LA ROCHE & CO |